Stock Analysis

Align Technology Full Year 2024 Earnings: EPS Misses Expectations

NasdaqGS:ALGN
Source: Shutterstock

Align Technology (NASDAQ:ALGN) Full Year 2024 Results

Key Financial Results

  • Revenue: US$4.00b (up 3.5% from FY 2023).
  • Net income: US$421.4m (down 5.3% from FY 2023).
  • Profit margin: 11% (down from 12% in FY 2023). The decrease in margin was driven by higher expenses.
  • EPS: US$5.63 (down from US$5.82 in FY 2023).
earnings-and-revenue-growth
NasdaqGS:ALGN Earnings and Revenue Growth February 7th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Align Technology EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.3%.

Looking ahead, revenue is forecast to grow 6.1% p.a. on average during the next 3 years, compared to a 7.8% growth forecast for the Medical Equipment industry in the US.

Performance of the American Medical Equipment industry.

The company's shares are down 3.1% from a week ago.

Balance Sheet Analysis

While earnings are important, another area to consider is the balance sheet. We have a graphic representation of Align Technology's balance sheet and an in-depth analysis of the company's financial position.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqGS:ALGN

Align Technology

Designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally.

Flawless balance sheet and slightly overvalued.

Community Narratives

Priced for AI perfection - cracks are emerging
Fair Value US$90.15|42.74% overvalued
ChadWisperer
ChadWisperer
Community Contributor
NVDA Market Outlook
Fair Value US$341.12|62.277% undervalued
NateF
NateF
Community Contributor
Karoon Energy (ASX:KAR) - Buy Baby Buy 🚀
Fair Value AU$5.10|70.294% undervalued
StockMan
StockMan
Community Contributor